These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 32535016)
1. Two decades of vaccine innovations for global public good: Report of the Developing Countries' Vaccine Manufacturers Network 20th meeting, 21-23 october 2019, Rio de Janeiro, Brazil. Pagliusi S; Dennehy M; Homma A Vaccine; 2020 Aug; 38(36):5851-5860. PubMed ID: 32535016 [TBL] [Abstract][Full Text] [Related]
2. Vaccines, inspiring innovation in health. Pagliusi S; Dennehy M; Kim H; Vaccine; 2018 Nov; 36(48):7430-7437. PubMed ID: 29789241 [TBL] [Abstract][Full Text] [Related]
3. The art of partnerships for vaccines. Pagliusi S; Che Y; Dong S Vaccine; 2019 Sep; 37(40):5909-5919. PubMed ID: 31447125 [TBL] [Abstract][Full Text] [Related]
6. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe. Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171 [TBL] [Abstract][Full Text] [Related]
7. Casting off vaccine supply charity -- the pace quickens. CVI goal: quality vaccines for all children. CVI Forum; 1995 Oct; (10):9-13. PubMed ID: 12290725 [TBL] [Abstract][Full Text] [Related]
8. Opportunities to accelerate immunization progress in middle-income countries. Zhu J; Cole CB; Fihman J; Adjagba A; Dasic M; Cernuschi T Vaccine; 2024 Apr; 42 Suppl 1():S98-S106. PubMed ID: 37460357 [TBL] [Abstract][Full Text] [Related]
9. Sustainable vaccine manufacturing in low- and middle-Income countries. Hayman B; Kumar Suri R; Downham M Vaccine; 2022 Nov; 40(50):7288-7304. PubMed ID: 36334966 [TBL] [Abstract][Full Text] [Related]
10. Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations. Mvundura M; Frivold C; Janik Osborne A; Soni P; Robertson J; Kumar S; Anena J; Gueye A; Menozzi-Arnaud M; Giersing B; Kahn AL; Scarna T; Kristensen D Vaccine; 2021 Dec; 39(49):7195-7207. PubMed ID: 34412922 [TBL] [Abstract][Full Text] [Related]
11. Costs of vaccine programs across 94 low- and middle-income countries. Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184 [TBL] [Abstract][Full Text] [Related]
12. Intellectual property rights and challenges for development of affordable human papillomavirus, rotavirus and pneumococcal vaccines: Patent landscaping and perspectives of developing country vaccine manufacturers. Chandrasekharan S; Amin T; Kim J; Furrer E; Matterson AC; Schwalbe N; Nguyen A Vaccine; 2015 Nov; 33(46):6366-70. PubMed ID: 26368398 [TBL] [Abstract][Full Text] [Related]
13. Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond. Chen S; Rodewald LE; Du AH; Tang S Infect Dis Poverty; 2024 Mar; 13(1):25. PubMed ID: 38475849 [TBL] [Abstract][Full Text] [Related]
14. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs. Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377 [TBL] [Abstract][Full Text] [Related]
15. Strengthening vaccination policies in Latin America: an evidence-based approach. Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196 [TBL] [Abstract][Full Text] [Related]
16. Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries. Giersing B; Shah N; Kristensen D; Amorij JP; Kahn AL; Gandrup-Marino K; Jarrahian C; Zehrung D; Menozzi-Arnaud M Vaccine; 2021 Dec; 39(49):7208-7219. PubMed ID: 34627624 [TBL] [Abstract][Full Text] [Related]
17. Developing Countries Vaccine Manufacturers Network (DCVMN): engaging to step up for vaccine discovery and access. Meeting report 2012. Pagliusi S; Makhoana M; Datla M; Leite L; Hendriks J; Gholami A; Huang W; Gao Y; Jadhav S; Harshavardhan GV; Wu Y; Suhardono M; Homma A Vaccine; 2013 Jun; 31(31):3111-5. PubMed ID: 23684836 [TBL] [Abstract][Full Text] [Related]
18. Improving Middle-Income Countries Access to Vaccines. A Blueprint to Overcome Current Challenges. Espinal C; Becerra-Posada F; Torres JR Ann Glob Health; 2023; 89(1):80. PubMed ID: 38025920 [TBL] [Abstract][Full Text] [Related]
19. Quality vaccines for all people: Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers' Network, 05-07th October 2015, Bangkok, Thailand. Pagliusi S; Ting CC; Khomvilai S; Vaccine; 2016 Jun; 34(31):3562-7. PubMed ID: 26947496 [TBL] [Abstract][Full Text] [Related]
20. The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs. Farlow A; Torreele E; Gray G; Ruxrungtham K; Rees H; Prasad S; Gomez C; Sall A; Magalhães J; Olliaro P; Terblanche P Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]